B2DB — Who said what, where, and when

Konstantinos Papamichail

Konstantinos Papamichail is scheduled to speak at ECCO'27 – 22nd Congress of ECCO on 3 March 2027.

Compiled from published conference agendas; not yet confirmed by Konstantinos. Is this you? Claim this profile.

About

Dr. Konstantinos Papamichail received his MD and PhD from the University of Athens, Medical School in Greece. After completing his Gastroenterology Fellowship in Evaggelismos General Hospital in Athens, Greece he performed Clinical Research Fellowships at the Inflammatory Bowel Disease (IBD) Center in Leuven, Belgium and the Beth Israel Deaconess Medical Center in Boston where he was recently promoted to Assistant Professor in Medicine at Harvard Medical School. Dr. Papamichail is widely recognized for his innovative research on the role of therapeutic drug monitoring (TDM) of biologics in IBD. He has received numerous awards, grants and distinctions including the very prestigious European Crohn’s and Colitis Organization (ECCO) Fellowship. Dr. Papamichail is a reviewer and editorial board member for numerous leading medical journals and he has been a member of the Scientific Committee of ECCO and he is currently a member of the Research Committee of ACG (American College of Gastroente

Upcoming

ECCO'27 – 22nd Congress of ECCO 3 March 2027 – 6 March 2027

Spoke alongside

People who have shared a session with Konstantinos at events on B2DB.

and 3 more people